Navigation Links
Reportlinker Adds European Markets for Interventional Cardiology Devices 2011 (15 Countries)
Date:4/7/2011

NEW YORK, April 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

European Markets for Interventional Cardiology Devices 2011 (15 Countries)

http://www.reportlinker.com/p0470760/European-Markets-for-Interventional-Cardiology-Devices-2011-15-Countries.html

In 2010, the European markets for interventional cardiology devices were valued at over euro1.5 billion. In 2010, the fastest growing European market for interventional cardiology devices as the United Kingdom. Over the forecast period, Scandinavia is expected to be the fastest growing market in Europe because it has relatively low DES penetration rates; as these penetration rates increase, they will boost market growth. Growth in countries such as Austria, France, and Switzerland are expected to slow over the forecast period due to decreases in prices across several device markets.

The European markets, as defined in this report, include:

- Germany,

- France,

- The United Kingdom (U.K.),

- Italy,

- Spain,

- Benelux (Belgium, Netherlands, and Luxembourg),

- Scandinavia (Finland, Denmark, Sweden, and Norway),

- Portugal,

- Austria and

- Switzerland

The interventional cardiology market includes:

- Drug-eluting stents,

- Bare-metal stents,

- PTCA balloon catheters,

- Interventional coronary catheters and guidewires,

- Diagnostic coronary catheters and guidewires,

- Coronary introducer sheaths,

- Embolic protection devices,

- Atherectomy devices,

- Coronary vascular closure devices,

- Optical coherence tomography (OCT) catheters

- Intravascular ultrasound (IVUS) catheters

In addition, this report covers the emerging markets for vulnerable plaque screening and treatment.

Within the European interventional cardiology market, companies such as Boston Scientific, Abbott Laboratories, Cordis and Medtronic lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.

TABLE OF CONTENTS

TABLE OF CONTENTS.I

LIST OF FIGURES.IX

LIST OF CHARTS.XXII

EXECUTIVE SUMMARY 1

1.1 EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS. 1

1.2 TREND ANALYSIS BY COUNTRY.. 2

1.3 PROCEDURE NUMBERS . 3

1.4 COUNTRY PROFILE . 4

1.4.1 Population 4

1.4.2 GDP per Capita 4

1.4.3 PCI and DES Penetration Rates .. 4

1.4.4 Price Index.. 4

1.5 BARE-METAL AND DRUG-ELUTING STENT MARKET 6

1.6 PTCA BALLOON CATHETER MARKET . 7

1.7 INTERVENTIONAL CORONARY CATHETER MARKET . 7

1.8 INTERVENTIONAL CORONARY GUIDEWIRE MARKET 7

1.9 CORONARY INTRODUCER SHEATH MARKET. 8

1.10 CORONARY EMBOLIC PROTECTION DEVICE MARKET .. 8

1.11 CORONARY ATHERECTOMY DEVICE MARKET.. 9

1.12 DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET.. 10

1.13 FRACTIONAL FLOW RESERVE (FFR) GUIDEWIRE MARKET . 11

1.14 INTRAVASCULAR ULTRASOUND (IVUS) CATHETER MARKET 11

1.15 CORONARY VASCULAR CLOSURE DEVICE (VCD)MARKET 12

1.16 OPTICAL COHERENCE TOMOGRAPHY (OCT) DEVICE MARKET. 13

1.17 VULNERABLE PLAQUE DEVICE MARKET .. 14

1.18 COMPETITIVE ANALYSIS 14

RESEARCH METHODOLOGY 16

2.1 RESEARCH SCOPE . 16

2.2 IDATA'S 9-STEP METHODOLOGY . 16

Step 1: Project Initiation & Team Selection . 17

Step 2: Prepare Data Systems and Perform Secondary Research. 18

Step 3: Preparation for Interviews & Questionnaire Design 19

Step 4: Performing Primary Research.. 20

Step 5: Research Analysis: Establishing Baseline Estimates 22

Step 6: Market Forecast and Analysis .. 23

Step 7: Identify Strategic Opportunities . 25

Step 8: Final Review and Market Release . 26

Step 9: Customer Feedback and Market Monitoring 26

EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS . 28

3.1 INTRODUCTION .. 28

3.1.1 Population at Risk. 28

3.2 CURRENCY EXCHANGE RATE. 30

3.3MARKET OVERVIEW 31

3.4MARKET BY SEGMENT 34

3.5MARKET BY COUNTRY .. 41

3.5.1.1 Germany 41

3.5.1.2 France.41

3.5.1.3 United Kingdom.41

3.5.1.4 Italy..42

3.5.1.5 Spain 42

3.5.1.6 Benelux ..42

3.5.1.7 Scandinavia .43

3.5.1.8 Portugal .43

3.5.1.9 Austria 43

3.5.1.10 Switzerland 43

3.6 TREND ANALYSIS BY COUNTRY 46

3.7MARKET DRIVERS AND LIMITERS 49

3.7.1 Market Drivers 49

3.7.2 Market Limiters.. 49

3.8 COMPETITIVE ANALYSIS .. 51

3.9MERGERS AND ACQUISITIONS 56

PROCEDURE NUMBERS. 57

4.1 TOTAL PROCEDURE NUMBERS .. 57

4.2 GERMANY. 62

4.3 FRANCE.. 63

4.4 UNITED KINGDOM 64

4.5 ITALY .. 65

4.6 SPAIN .. 66

4.7 BENELUX .. 67

4.8 SCANDINAVIA . 68

4.9 PORTUGAL 69

4.10 AUSTRIA . 70

4.11 SWITZERLAND.. 71

COUNTRY PROFILES 72

5.1 INTRODUCTION .. 72

5.1.1 Population. 72

5.1.2 GDP per Capita . 72

5.1.3 PCI and DES Penetration Rates 72

5.1.4 Price Index 73

5.2 GERMANY. 74

5.3 FRANCE.. 75

5.4 UNITED KINGDOM 76

5.5 ITALY .. 77

5.6 SPAIN .. 78

5.7 BENELUX .. 79

5.8 SCANDINAVIA . 80

5.9 PORTUGAL 81

5.10 AUSTRIA . 82

5.11 SWITZERLAND.. 83

CORONARY STENT MARKET 84

6.1 INTRODUCTION .. 84

6.2MARKET OVERVIEW 86

6.3MARKET ANALYSIS AND FORECAST .. 93

6.3.1 Total Coronary Stent Market.. 93

6.3.2 Drug-Eluting Stent Market 101

6.3.3 Bare-Metal Stent Market 109

6.4MARKET DRIVERS AND LIMITERS . 117

6.4.1 Drug-Eluting Stent Market 117

6.4.1.1 Market Drivers.117

6.4.1.2 Market Limiters ..117

6.4.2 Bare-Metal Stent Markets.. 119

6.4.2.1 Market Drivers.119

6.4.2.2 Market Limiters ..119

6.5 COMPETITIVE ANALYSIS 121

6.5.1 Emerging Competitors. 128

6.5.2 Bioabsorbable Coronary Stents.. 130

6.5.3 Bifurcated Coronary Stents .. 134

PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY BALLOON

CATHETER MARKET. 137

7.1 INTRODUCTION 137

7.1.1 Balloon Types .. 137

7.1.2 Drug-Eluting Balloons. 138

7.2MARKET ANALYSIS AND FORECAST 139

7.3 PROCEDURES. 147

7.3.1 Units per Procedure.. 147

7.3.2 Units Sold by Indication . 148

7.4MARKET DRIVERS AND LIMITERS . 151

7.4.1 Market Drivers. 151

7.4.2 Market Limiters 151

7.5 COMPETITIVE ANALYSIS 152

INTERVENTIONAL CORONARY CATHETER MARKET.. 156

8.1 INTRODUCTION 156

8.1.1 Units per Procedure.. 157

TABLE OF CONTENTS

© iData Research Inc., 2011 www.idataresearch.net v

8.2MARKET ANALYSIS AND FORECAST 158

8.3MARKET DRIVERS AND LIMITERS . 166

8.3.1 Market Drivers. 166

8.3.2 Market Limiters 166

8.4 COMPETITIVE ANALYSIS 168

INTERVENTIONAL CORONARY GUIDEWIRE MARKET 172

9.1 INTRODUCTION 172

9.1.1 Device Construction . 172

9.1.2 Hydrophilic Guidewires.. 173

9.1.3 Units per Procedure.. 173

9.2MARKET ANALYSIS AND FORECAST 174

9.3MARKET DRIVERS AND LIMITERS . 182

9.3.1 Market Drivers. 182

9.3.2 Market Limiters 182

9.4 COMPETITIVE ANALYSIS 184

CORONARY INTRODUCER SHEATH MARKET.. 188

10.1 INTRODUCTION . 188

10.1.1 The Femoral Approach. 189

10.1.2 Radial/Brachial Approach.. 189

10.2MARKET OVERVIEW.. 190

10.2.1 Units per Procedure 196

10.2.2 Coronary Introducer Sheath Market by Access Site.. 197

10.3MARKET ANALYSIS AND FORECAST . 200

10.3.1 Total Coronary Introducer Sheath Market . 200

10.3.2 Standard Coronary Introducer Sheath Market. 208

10.3.3 Coronary Micro-Introducer Sheath Market .. 216

10.4MARKET DRIVERS AND LIMITERS .. 224

10.4.1 Market Drivers.. 224

10.4.2 Market Limiters. 224

10.5 COMPETITIVE ANALYSIS . 226

CORONARY EMBOLIC PROTECTION DEVICE MARKET . 229

11.1 INTRODUCTION . 229

11.1.1 Saphenous Vein Grafts.. 229

11.1.2 Protection Mechanism .. 230

11.2MARKET ANALYSIS AND FORECAST . 231

11.3MARKET DRIVERS AND LIMITERS .. 240

11.3.1 Market Drivers.. 240

11.3.2 Market Limiters. 241

11.4 COMPETITIVE ANALYSIS . 242

CORONARY ATHERECTOMY DEVICE MARKET. 245

12.1 INTRODUCTION . 245

12.1.1 Atherectomy 245

12.1.2 Device Technologies .. 246

12.1.2.1 Mechanical Atherectomy .246

12.1.2.2 Laser Atherectomy ..246

12.1.2.3 Directional Coronary Atherectomy (DCA).246

12.2MARKET ANALYSIS & FORECAST .. 247

12.3MARKET DRIVERS AND LIMITERS .. 255

12.3.1 Market Drivers.. 255

12.3.2 Market Limiters. 256

12.4 COMPETITIVE ANALYSIS . 257

DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET.. 260

13.1 INTRODUCTION . 260

13.2MARKET OVERVIEW.. 261

13.3MARKET ANALYSIS AND FORECAST . 268

13.3.1 Total Diagnostic Coronary Catheter and Guidewire Market 268

13.3.2 Diagnostic Catheter Market .. 275

13.3.3 Diagnostic Guidewire Market 283

13.4MARKET DRIVERS AND LIMITERS .. 291

13.4.1 Market Drivers.. 291

13.4.2 Market Limiters. 291

13.5 COMPETITIVE ANALYSIS . 293

FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET . 298

14.1 INTRODUCTION . 298

14.2MARKET ANALYSIS AND FORECAST . 299

14.3MARKET DRIVERS AND LIMITERS .. 307

14.3.1 Market Drivers.. 307

14.3.2 Market Limiters. 307

14.4 COMPETITIVE ANALYSIS . 308

CORONARY VASCULAR CLOSURE DEVICE MARKET 311

15.1 INTRODUCTION . 311

15.1.1 Invasive and Non-Invasive Devices 311

15.2MARKET OVERVIEW.. 312

15.3MARKET ANALYSIS AND FORECAST . 319

15.3.1 Total Coronary VCD Market. 319

15.3.2 Total Coronary VCD Market by Access Site . 327

15.3.3 Invasive Coronary VCD Market .. 329

15.3.4 Non-Invasive Coronary VCD Market 337

15.4MARKET DRIVERS AND LIMITERS .. 345

15.4.1 Market Drivers.. 345

15.4.2 Market Limiters. 345

15.5 COMPETITIVE ANALYSIS . 347

INTRAVASCULAR ULTRASOUND CATHETER MARKET.. 351

16.1 INTRODUCTION . 351

16.1.1 Pre-Stenting Applications 351

16.1.2 Post-Stenting Applications.. 352

16.1.3 IVUS Console Penetration.. 352

16.2MARKET ANALYSIS AND FORECAST . 353

16.3 PENETRATION RATE .. 361

16.4MARKET DRIVERS AND LIMITERS .. 362

16.4.1 Market Drivers.. 362

16.4.2 Market Limiters. 363

16.5 COMPETITIVE ANALYSIS . 364

OPTICAL COHERENCE TOMOGRAPHY CATHETER MARKET.. 367

17.1 INTRODUCTION . 367

17.1.1 OCT Applications 368

17.2MARKET ANALYSIS AND FORECAST . 370

17.3 PENETRATION RATE .. 378

17.4MARKET DRIVERS AND LIMITERS .. 379

17.4.1 Market Drivers.. 379

17.4.2 Market Limiters. 380

17.5 COMPETITIVE ANALYSIS . 381

VULNERABLE PLAQUE DEVICE MARKET 383

18.1 INTRODUCTION . 383

18.1.1 Vulnerable Plaque Screening Technologies .. 384

18.1.1.1 Intravascular Ultrasound (IVUS) 384

18.1.1.2 Optical Coherence Tomography (OCT) ..384

18.1.1.3 Raman Spectroscopy..385

18.1.1.4 Near Infrared (NIR) Spectroscopy..385

18.1.1.5 Thermography385

18.1.1.6 Intravascular Magnetic Resonance Imaging (IVMRI) .385

18.1.1.7 Computed Tomography (CT).386

18.1.2 Potential Vulnerable Plaque Treatments. 386

18.1.2.1 Stents..386

18.1.2.2 Pharmaceuticals ..386

18.1.2.3 Photodynamic Therapies .387

18.1.2.4 Cryotherapy 387

18.2 TARGET POPULATION 388

18.3MARKET ANALYSIS AND FORECAST . 391

18.3.1 Total Potential Market.. 391

18.3.2 Potential Vulnerable Plaque Screening Market .. 394

18.3.3 Potential Vulnerable Plaque Treatment Market.. 399

18.4MARKET DRIVERS AND LIMITERS .. 403

18.4.1 Market Drivers.. 403

18.4.2 Market Limiters. 403

18.5 COMPETITIVE ANALYSIS . 404

18.5.1 Past Companies and Technology. 407

ABBREVIATIONS 409

LIST OF FIGURES

EXECUTIVE SUMMARY 1

RESEARCH METHODOLOGY.. 16

EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS 28

Figure 3-1: Exchange Rates for the Euro (euro), 2010. 30

Figure 3-2: Interventional Cardiology Device Markets, Europe, 2007 – 2017. 32

Figure 3-3: Interventional Cardiology Device Markets Segmented by Device

Type, Europe, 2007 – 2017 (euroM) (Part 1 of 2) .. 35

Figure 3-4: Interventional Cardiology Device Markets Segmented by Device

Type, Europe, 2007 – 2017 (US$M) (Part 1 of 2).. 37

Figure 3-5: Interventional Cardiology Device Markets Segmented by Device

Type, Europe, 2007 – 2017 (US$M) (Part 2 of 2).. 38

Figure 3-6: Interventional Cardiology Device Markets by Country, Europe,

2007 – 2017 (euroM) 44

Figure 3-7: Interventional Cardiology Markets by Country, Europe, 2007 – 2017

(US$M) 45

Figure 3-8: Interventional Cardiology Device Markets Growth Rates by Country,

Europe, 2007 – 2017 .. 47

Figure 3-9: Drivers and Limiters, Interventional Cardiology Device Markets,

Europe, 2010 . 50

Figure 3-10: Leading Competitors, Interventional Cardiology Device Markets,

Europe, 2010 (Part 1 of 2) 53

Figure 3-11: Leading Competitors, Interventional Cardiology Device Markets,

Europe, 2010 (Part 2 of 2) 54

PROCEDURE NUMBERS. 57

Figure 4-1: Angioplasty Procedures, Europe, 2007 – 2017 . 58

Figure 4-2: Angiography Procedures, Europe, 2007 – 2017 .. 60

Figure 4-3: Angioplasty and Angiography Procedures, Germany, 2007 – 2017.. 62

Figure 4-4: Angioplasty and Angiography Procedures, France, 2007 – 2017 .. 63

Figure 4-5: Angioplasty and Angiography Procedures, U.K., 2007 – 2017 .. 64

Figure 4-6: Angioplasty and Angiography Procedures, Italy, 2007 – 2017 .. 65

Figure 4-7: Angioplasty and Angiography Procedures, Spain, 2007 – 2017. 66

Figure 4-8: Angioplasty and Angiography Procedures, Benelux, 2007 – 2017 67

Figure 4-9: Angioplasty and Angiography Procedures, Scandinavia, 2007 – 2017 68

Figure 4-10: Angioplasty and Angiography Procedures, Portugal, 2007 – 2017. 69

Figure 4-11: Angioplasty and Angiography Procedures, Austria, 2007 – 2017 .. 70

Figure 4-12: Angioplasty and Angiography Procedures, Switzerland,

2007 – 2017 71

COUNTRY PROFILES .. 72

Figure 5-1: Country Indicators, 2010 73

CORONARY STENT MARKET. 84

Figure 6-1: Total Coronary Stent Units Sold by Segment, Europe, 2007 – 2017 .. 87

Figure 6-2: Total Coronary Stent ASP by Segment, Europe 2007 – 2017 (euro) . 88

Figure 6-3: Total Coronary Stent ASP by Segment, Europe 2007 – 2017 (US$) .. 88

Figure 6-4: Total Coronary Stent Market by Segment, Europe, 2007 – 2017 (euroM) 89

Figure 6-5: Total Coronary Stent Market by Segment, Europe, 2007 – 2017

(US$M) 89

Figure 6-6: Total Coronary Stent Market, Europe, 2007 – 2017 (euro) .. 94

Figure 6-7: Total Coronary Stent Market, Europe, 2007 – 2017 (US$) .. 94

Figure 6-8: Total Coronary Stent Units Sold by Country, Europe, 2007 – 2017 96

Figure 6-9: Total Coronary Stent ASP by Country, Europe, 2007 – 2017 (euro). 97

Figure 6-10: Total Coronary Stent ASP by Country, Europe, 2007 – 2017 (US$) 98

Figure 6-11: Total Coronary Stent Market by Country, Europe, 2007 – 2017

(euroM).. 99

Figure 6-12: Total Coronary Stent Market by Country, Europe, 2007 – 2017

(US$M) . 100

Figure 6-13: Drug-Eluting Stent Market, Europe, 2007 – 2017 (euro).. 102

Figure 6-14: Drug-Eluting Stent Market, Europe, 2007 – 2017 (US$) . 102

Figure 6-15: Drug-Eluting Stent Units Sold by Country, Europe, 2007 – 2017 .. 104

Figure 6-16: Drug-Eluting Stent ASP by Country, Europe, 2007 – 2017 (euro) . 105

Figure 6-17: Drug-Eluting Stent ASP by Country, Europe, 2007 – 2017 (US$) . 106

Figure 6-18: Drug-Eluting Stent Market by Country, Europe, 2007 – 2017

(euroM) 107

Figure 6-19: Drug-Eluting Stent Market by Country, Europe, 2007 – 2017

(US$M) . 108

Figure 6-20: Bare-Metal Stent Market, Europe, 2007 – 2017 (euro).. 110

Figure 6-21: Bare-Metal Stent Market, Europe, 2007 – 2017 (US$) . 110

Figure 6-22: Bare-Metal Stent Units Sold by Country, Europe, 2007 – 2017 .. 112

Figure 6-23: Bare-Metal Stent ASP by Country, Europe, 2007 – 2017 (euro) . 113

Figure 6-24: Bare-Metal Stent ASP by Country, Europe, 2007 – 2017 (US$) . 114

Figure 6-25: Bare-Metal Stent Market by Country, Europe, 2007 – 2017 (euroM).. 115

Figure 6-26: Bare-Metal Stent Market by Country, Europe, 2007 – 2017

(US$M) . 116

Figure 6-27: Drivers and Limiters, Drug-Eluting Stent Market, Europe, 2010 . 119

Figure 6-28: Drivers and Limiters, Bare-Metal Stent Market, Europe, 2010 120

Figure 6-29: Leading Competitors, Drug-Eluting Stent Market, Europe, 2010 124

Figure 6-30: Leading Competitors, Bare-Metal Stent Market, Europe, 2010 126

Figure 6-31: Potential Market for Bioabsorbable Stents, Europe, 2010 – 2017

(euro) 131

Figure 6-32: Potential Market for Bioabsorbable Stents, Europe, 2010 – 2017

(US$) . 132

Figure 6-33: Bifurcated Coronary Stent Market, Europe, 2010 – 2017 (euro) 135

Figure 6-34: Bifurcated Coronary Stent Market, Europe, 2010 – 2017 (US$) . 135

PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY

BALLOON CATHETER MARKET.. 137

Figure 7-1: PTCA Balloon Catheter Market, Europe, 2007 – 2017 (euro) .. 140

Figure 7-2: PTCA Balloon Catheter Market, Europe, 2007 – 2017 (US$). 140

Figure 7-3: PTCA Balloon Catheter Units Sold by Country, Europe,

2007 – 2017. 142

Figure 7-4: PTCA Balloon Catheter ASP by Country, Europe, 2007 – 2017 (euro) . 143

Figure 7-5: PTCA Balloon Catheter ASP by Country, Europe, 2007 – 2017

(US$) . 144

Figure 7-6: PTCA Balloon Catheter Market by Country, Europe, 2007 – 2017

(euroM) 145

Figure 7-7: PTCA Balloon Catheter Market by Country, Europe, 2007 – 2017

(US$M) . 146

Figure 7-8: Units Used Per Procedure, PTCA Balloon Catheter Market, Europe,

2007 – 2017. 147

Figure 7-9: Percentage of Units Sold by Indication, PTCA Balloon Catheter

Market, Europe, 2007 – 2017 .. 148

Figure 7-10: Percentage of Units Sold by Indication, PTCA Balloon Catheter

Market, Europe, 2007 – 2017 .. 149

Figure 7-11: Total Procedures, PTCA Balloon Catheter Market, Europe,

2007 – 2017. 150

Figure 7-12: Drivers and Limiters, PTCA Balloon Catheter Market, Europe,

2010 152

Figure 7-13 Leading Competitors, PTCA Balloon Catheter Market, Europe,

2010 154

INTERVENTIONAL CORONARY CATHETER MARKET 156

Figure 8-1: Units Per Procedure, Interventional Coronary Catheter Market,

Europe, 2007 – 2017 157

Figure 8-2: Interventional Coronary Catheter Market, Europe, 2007 – 2017 (euro) . 159

Figure 8-3: Interventional Coronary Catheter Market, Europe, 2007 – 2017

(US$) . 159

Figure 8-4: Interventional Coronary Catheter Units Sold by Country, Europe,

2007 – 2017. 161

Figure 8-5: Interventional Coronary Catheter ASP by Country, Europe,

2007 – 2017 (euro) . 162

Figure 8-6: Interventional Coronary Catheter ASP by Country, Europe,

2007 – 2017 (US$) 163

Figure 8-7: Interventional Coronary Catheter Market by Country, Europe,

2007 – 2017 (euroM) . 164

Figure 8-8: Interventional Catheter Market by Country, Europe, 2007 – 2017

(US$M) . 165

Figure 8-9: Drivers and Limiters, Interventional Coronary Catheter Market,

2010 167

Figure 8-10: Leading Competitors, Interventional Coronary Catheter Market,

Europe, 2010 .. 170

INTERVENTIONAL CORONARY GUIDEWIRE MARKET.. 172

Figure 9-1: Units Used per Procedure, Interventional Coronary Guidewire

Market, Europe, 2007 – 2017 .. 173

Figure 9-2: Interventional Coronary Guidewire Market, Europe, 2007 – 2017

(euro) 175

Figure 9-3: Interventional Coronary Guidewire Market, Europe, 2007 – 2017

(US$) . 175

Figure 9-4: Interventional Coronary Guidewire Units Sold by Country, Europe,

2007 – 2017. 177

Figure 9-5: Interventional Coronary Guidewire ASP by Country, Europe,

2007 – 2017 (euro) . 178

Figure 9-6: Interventional Coronary Guidewire ASP by Country, Europe,

2007 – 2017 (US$) 179

Figure 9-7: Interventional Coronary Guidewire Market by Country, Europe,

2007 – 2017 (euroM) . 180

Figure 9-8: Interventional Coronary Guidewire Market by Country, Europe,

2007 – 2017 (US$M) .. 181

Figure 9-9: Drivers and Limiters, Interventional Coronary Guidewire Market,

Europe, 2010 .. 183

Figure 9-10: Leading Competitors, Interventional Coronary Guidewire Market,

Europe, 2010 .. 186

CORONARY INTRODUCER SHEATH MARKET . 188

Figure 10-1: Units Sold by Segment, Coronary Introducer Sheath Market,

Europe, 2007 – 2017 190

Figure 10-2: Coronary Introducer Sheath ASP by Segment, Europe, 2007 – 2017

(euro) 191

Figure 10-3: Coronary Introducer Sheath ASP by Segment, Europe, 2007 – 2017

(US$) . 191

Figure 10-4: Total Coronary Introducer Sheath Market by Segment, Europe,

2007 – 2017 (euroM) . 192

Figure 10-5: Total Coronary Introducer Sheath Market by Segment, Europe,

2007 – 2017 (US$M) .. 192

Figure 10-6: Units per Procedure, Coronary Introducer Sheath Market, Europe,

2007 – 2017. 196

Figure 10-7: Coronary Introducer Sheath Market by Access Site, Europe,

2007 – 2017. 198

Figure 10-8: Total Coronary Introducer Sheath Market, Europe, 2007 – 2017 (euro)201

Figure 10-9: Total Coronary Introducer Sheath Market, Europe, 2007 – 2017

(US$) . 201

Figure 10-10: Total Coronary Introducer Sheath Units Sold by Country, Europe,

2007 – 2017. 203

Figure 10-11: Coronary Introducer Sheath ASP by Country, Europe, 2007 – 2017

(euro) 204

Figure 10-12: Coronary Introducer Sheath ASP by Country, Europe, 2007 – 2017

(US$) . 205

Figure 10-13: Coronary Introducer Sheath Market by Country, Europe,

2007 – 2017 (euroM) . 206

Figure 10-14: Coronary Introducer Sheath Market by Country, Europe,

2007 – 2017 (US$M) .. 207

Figure 10-15: Standard Coronary Introducer Sheath Market, Europe,

2007 – 2017 (euro) . 209

Figure 10-16: Standard Coronary Introducer Sheath Market, Europe,

2007 – 2017 (US$) 209

Figure 10-17: Standard Coronary Introducer Sheath Units Sold by Country,

Europe, 2007 – 2017 211

Figure 10-18: Standard Introducer Sheath ASP by Country, Europe, 2007 – 2017

(euro) 212

Figure 10-19: Standard Introducer Sheath ASP by Country, Europe, 2007 – 2017

(US$) . 213

Figure 10-20: Standard Introducer Sheath Market by Country, Europe,

2007 – 2017 (euroM) . 214

Figure 10-21: Standard Introducer Sheath Market by Country, Europe,

2007 – 2017 (US$M) .. 215

Figure 10-22: Coronary Micro-Introducer Sheath Market, Europe, 2007 – 2017

(euro) 217

Figure 10-23: Coronary Micro-Introducer Sheath Market, Europe, 2007 – 2017

(US$) . 217

Figure 10-24: Coronary Micro-Introducer Sheath Units Sold by Country, Europe,

2007 – 2017. 219

Figure 10-25: Coronary Micro-Introducer Sheath ASP by Country, Europe,

2007 – 2017 (euro) . 220

Figure 10-26: Coronary Micro-Introducer Sheath ASP by Country, Europe,

2007 – 2017 (US$) 221

Figure 10-27: Coronary Micro-Introducer Sheath Market by Country, Europe,

2007 – 2017 (euroM) . 222

Figure 10-28: Coronary Micro-Introducer Sheath Market by Country, Europe,

2007 – 2017 (US$M) .. 223

Figure 10-29: Drivers and Limiters, Coronary Introducer Sheath Market,

Europe, 2010 .. 225

Figure 10-30: Leading Competitors, Coronary Introducer Sheath Market, Europe,

2010 .. 227

CORONARY EMBOLIC PROTECTION DEVICE MARKET. 229

Figure 11-1: Coronary Embolic Protection Device Market, Europe, 2007 – 2017

(euro) 232

Figure 11-2: Coronary Embolic Protection Device Market, Europe, 2007 – 2017

(US$) . 232

Figure 11-3 Coronary Embolic Protection Device Units Sold by Country,

Europe, 2007 – 2017 234

Figure 11-4: Coronary Embolic Protection Device ASP by Country, Europe,

2007 – 2017 (euro) . 235

Figure 11-5: Coronary Embolic Protection Device ASP by Country, Europe,

2007 – 2017 (US$) 236

Figure 11-6: Coronary Embolic Protection Device Market by Country, Europe,

2007 – 2017 (euroM) . 237

Figure 11-7: Coronary Embolic Protection Device Market by Country, Europe,

2007 – 2017 (US$M) .. 238

Figure 11-8: Penetration Rate for Angioplasties, Coronary Embolic Protection

Device Market, Europe, 2007 – 2017 239

Figure 11-9: Drivers and Limiters, Coronary Embolic Protection Device Market,

Europe, 2010 .. 241

Figure 11-10: Leading Competitors, Coronary Embolic Protection Device Market,

Europe, 2010 .. 243

CORONARY ATHERECTOMY DEVICE MARKET . 245

Figure 12-1: Total Coronary Atherectomy Device Market, Europe, 2007 – 2017

(euro) 248

Figure 12-2: Total Coronary Atherectomy Device Market, Europe, 2007 – 2017

(US$) . 248

Figure 12-3: Coronary Atherectomy Device Units Sold by Country, Europe,

2007 – 2017. 250

Figure 12-4: Coronary Atherectomy Device ASP by Country, Europe,

2007 – 2017 (euro) . 251

Figure 12-5: Coronary Atherectomy Device ASP by Country, Europe,

2007 – 2017 (US$) 252

Figure 12-6: Coronary Atherectomy Device Market by Country, Europe,

2007 – 2017 (euroM) . 253

Figure 12-7: Coronary Atherectomy Device Market by Country, Europe,

2007 – 2017 (US$M) .. 254

Figure 12-8: Drivers and Limiters, Coronary Atherectomy Device Market, Europe

2010 256

Figure 12-9: LeadingCompetitors, Coronary Atherectomy Device Market,

Europe, 2010 .. 258

DIAGNOSTIC CORONARY CATHETER AND GUIDEWIRE MARKET 260

Figure 13-1: Units per Procedure, Diagnostic Coronary Catheter and Guidewire

Market, Europe, 2007 – 2017 .. 262

Figure 13-2: Units Sold, Diagnostic Coronary Catheter and Guidewire Market,

Europe, 2007 – 2017 262

Figure 13-3: Diagnostic Coronary Catheter and Guidewire ASP by Segment,

Europe 2007 – 2017 (euro) . 263

Figure 13-4: Diagnostic Coronary Catheter and Guidewire ASP by Segment,

Europe 2007 – 2017 (US$) 263

Figure 13-5: Diagnostic Coronary Catheter and Guidewire Market by Segment,

Europe, 2007 – 2017 (euroM) 264

Figure 13-6: Diagnostic Coronary Catheter and Guidewire Market by Segment,

Europe, 2007 – 2017 (US$M).. 264

Figure 13-7: Total Diagnostic Catheter and Guidewire Market, Europe,

2007 – 2017 (euro) . 269

Figure 13-8: Total Diagnostic Catheter and Guidewire Market, Europe,

2007 – 2017 (US$) 269

Figure 13-9: Diagnostic Catheter and Guidewire Units Sold by Country, Europe,

2007 – 2017. 270

Figure 13-10: Diagnostic Catheter and Guidewire ASP by Country, Europe,

2007 – 2017 (euro) . 271

Figure 13-11: Diagnostic Catheter and Guidewire ASP by Country, Europe,

2007 – 2017 (US$) 272

Figure 13-12: Diagnostic Catheter and Guidewire Market by Country, Europe,

2007 – 2017 (euroM) . 273

Figure 13-13: Diagnostic Catheter and Guidewire Market by Country, Europe,

2007 – 2017 (US$M) .. 274

Figure 13-14: Diagnostic Catheter Market, Europe, 2007 – 2017 (euro).. 276

Figure 13-15: Diagnostic Catheter Market, Europe, 2007 – 2017 (US$) . 276

Figure 13-16: Diagnostic Catheter Units Sold by Country, Europe,

2007 – 2017. 278

Figure 13-17: Diagnostic Catheter ASP by Country, Europe, 2007 – 2017 (euro). 279

Figure 13-18: Diagnostic Catheter ASP by Country, Europe, 2007 – 2017 (US$) 280

Figure 13-19: Diagnostic Catheter Market by Country, Europe, 2007 – 2017

(euroM) 281

Figure 13-20: Diagnostic Catheter Market by Country, Europe, 2007 – 2017

(US$M) . 282

Figure 13-21: Diagnostic Guidewire Market, Europe, 2007 – 2017 (euro) 284

Figure 13-22: Diagnostic Guidewire Market, Europe, 2007 – 2017 (US$) . 284

Figure 13-23: Diagnostic Guidewire Units Sold by Country, Europe,

2007 – 2017. 286

Figure 13-24: Diagnostic Guidewire ASP by Country, Europe, 2007 – 2017 (euro). 287

Figure 13-25: Diagnostic Guidewire ASP by Country, Europe, 2007 – 2017

(US$) . 288

Figure 13-26: Diagnostic Guidewire Market by Country, Europe, 2007 – 2017

(euroM) 289

Figure 13-27: Diagnostic Guidewire Market by Country, Europe, 2007 – 2017

(US$M) . 290

Figure 13-28: Drivers and Limiters, Diagnostic Catheter and Guidewire Market,

Europe, 2010 .. 292

Figure 13-29: Leading Competitors, Diagnostic Catheter and Guidewire Market,

Europe, 2010 .. 294

FRACTIONAL FLOW RESERVE GUIDEWIRE MARKET 298

Figure 14-1: Fractional Flow Reserve Guidewire Market, Europe, 2007 – 2017

(euro) 300

Figure 14-2: Fractional Flow Reserve Guidewire, Europe, 2007 – 2017 (US$) .. 300

Figure 14-3: Fractional Flow Reserve Guidewire Units Sold by Country, Europe,

2007 – 2017. 302

Figure 14-4: Fractional Flow Reserve Guidewire ASP by Country, Europe,

2007 – 2017 (euro) . 303

Figure 14-5: Fractional Flow Reserve Guidewire ASP by Country, Europe,

2007 – 2017 (US$) 304

Figure 14-6: Fractional Flow Reserve Guidewire Market by Country, Europe,

2007 – 2017 (euroM) . 305

Figure 14-7: Fractional Flow Reserve Guidewire Market by Country, Europe,

2007 – 2017 (US$M) .. 306

Figure 14-8: Drivers and Limiters, Fractional Flow Reserve Guidewire Market,

Europe, 2007 – 2017 308

Figure 14-9: Leading Competitors, Fractional Flow Reserve Guidewire Market,

Europe, 2010 .. 309

CORONARY VASCULAR CLOSURE DEVICE MARKET. 311

Figure 15-1: Total Coronary VCD Units Sold by Segment, Europe,

2007 – 2017. 313

Figure 15-2: Total Coronary VCD ASP by Segment, Europe 2007 – 2017 (euro) 313

Figure 15-3: Total Coronary VCD ASP by Segment, Europe 2007 – 2017

(US$) . 314

Figure 15-4: Total Coronary VCD Device Market by Segment, Europe,

2007 – 2017 (euroM) . 314

Figure 15-5: Total Coronary VCD Market by Segment, Europe, 2007 – 2017

(US$M) . 315

Figure 15-6: Total Coronary VCD Market, Europe, 2007 – 2017 (euro) .. 320

Figure 15-7: Total Coronary VCD Market, Europe, 2007 – 2017 (US$) 320

Figure 15-8 Total Coronary VCD Units Sold by Country, Europe, 2007 – 2017 322

Figure 15-9 Total Coronary VCD ASP by Country, Europe, 2007 – 2017 (euro) . 323

Figure 15-10: Total Coronary VCD ASP by Country, Europe, 2007 – 2017

(US$) . 324

Figure 15-11: Total Coronary VCD Market by Country, Europe, 2007 – 2017

(euroM) 325

Figure 15-12: Total Coronary VCD Market by Country, Europe, 2007 – 2017

(US$M) . 326

Figure 15-13: Total Coronary VCD Market by Access Site, Europe,

2007 – 2017. 327

Figure 15-14: Invasive Coronary VCD Market, Europe, 2007 – 2017 (euro) . 330

Figure 15-15: Invasive Coronary VCD Market, Europe, 2007 – 2017 (US$) .. 330

Figure 15-16 Invasive Coronary VCD Units Sold by Country, Europe,

2007 – 2017. 332

Figure 15-17 Invasive Coronary VCD ASP by Country, Europe, 2007 – 2017

(euro) 333

Figure 15-18: Invasive Coronary VCD ASP by Country, Europe, 2007 – 2017

(US$) . 334

Figure 15-19: Invasive Coronary VCD Market by Country, Europe, 2007 – 2017

(euroM) 335

Figure 15-20: Invasive Coronary VCD Market by Country, Europe, 2007 – 2017

(US$M) . 336

Figure 15-21: Non-Invasive Coronary VCD Market, Europe, 2007 – 2017 (euro) 338

Figure 15-22: Non-Invasive Coronary VCD Market, Europe, 2007 – 2017 (US$)338

Figure 15-23 Non-Invasive Coronary VCD Units Sold by Country, Europe,

2007 – 2017. 340

Figure 15-24 Non-Invasive Coronary VCD ASP by Country, Europe,

2007 – 2017 (euro) . 341

Figure 15-25: Non-Invasive Coronary VCD ASP by Country, Europe,

2007 – 2017 (US$) 342

Figure 15-26: Non-Invasive Coronary VCD Market by Country, Europe,

2007 – 2017 (euroM) . 343

Figure 15-27: Non-Invasive Coronary VCD Market by Country, Europe,

2007 – 2017 (US$M) .. 344

Figure 15-28: Drivers and Limiters, Coronary VCD Market, Europe, 2010 .. 346

Figure 15-29: Leading Competitors, Coronary VCD Market, Europe, 2010 . 349

INTRAVASCULAR ULTRASOUND CATHETER MARKET 351

Figure 16-1: IVUS Catheter Market, Europe, 2007 – 2017 (euro) 354

Figure 16-2: IVUS Catheter Market, Europe, 2007 – 2017 (US$) . 354

Figure 16-3: IVUS Catheter Units Sold by Country, Europe, 2007 – 2017 356

Figure 16-4: IVUS Catheter ASP by Country, Europe, 2007 – 2017 (euro) . 357

Figure 16-5: IVUS Catheter ASP by Country, Europe, 2007 – 2017 (US$) 358

Figure 16-6: IVUS Catheter Market by Country, Europe, 2007 – 2017 (euroM) 359

Figure 16-7: IVUS Catheter Market by Country, Europe, 2007 – 2017 (US$M) . 360

Figure 16-8: Penetration Rate, IVUS Catheter Market, Europe, 2007 – 2017 361

Figure 16-9: Market Drivers and Limiters, IVUS Catheter Market, Europe,

2010 363

Figure 16-10: Leading Competitors, IVUS Catheter Market, Europe, 2010 .. 365

OPTICAL COHERENCE TOMOGRAPHY CATHETER MARKET. 367

Figure 17-1: OCT Catheter Market, Europe, 2007 – 2017 (euro) . 371

Figure 17-2: OCT Catheter Market, Europe, 2007 – 2017 (US$) 371

Figure 17-3: OCT Catheter Units Sold by Country, Europe, 2007 – 2015.. 373

Figure 17-4: OCT Catheter ASP by Country, Europe, 2007 – 2015 (euro) 374

Figure 17-5: OCT Catheter ASP by Country, Europe, 2007 – 2015 (US$) . 375

Figure 17-6: OCT Catheter Market by Country, Europe, 2007 – 2015 (euroM) . 376

Figure 17-7: OCT Catheter Market by Country, Europe, 2007 – 2015 (US$M) 377

Figure 17-8: Penetration Rate, OCT Catheter Market, Europe, 2007 – 2017. 378

Figure 17-9: Drivers and Limiters, OCT Catheter Market, Europe, 2010 380

Figure 17-10: Leading Competitors, OCT Catheter Market, Europe, 2010. 382

VULNERABLE PLAQUE DEVICE MARKET.. 383

Figure 18-1: Target Population, Potential Market for Vulnerable Plaque, Europe,

2007 – 2017. 389

Figure 18-2: Maximum Potential Market for Vulnerable Plaque, Europe,

2010 – 2017 (euroM) . 392

Figure 18-3: Maximum Potential Market for Vulnerable Plaque, Europe,

2010 – 2017 (US$M) .. 392

Figure 18-4: Potential Market for Vulnerable Plaque Screening, Europe,

2010 – 2017 (euro) . 396

Figure 18-5: Potential Market for Vulnerable Plaque Screening, Europe,

2010 – 2017 (US$) 397

Figure 18-6: Potential Market for Vulnerable Plaque Treatment, Europe,

2013 – 2017 (euro) . 400

Figure 18-7: Potential Market for Vulnerable Plaque Treatment, Europe,

2013 – 2017 (US$) 401

Figure 18-8: Drivers and Limiters, Vulnerable Plaque Device Market, Europe,

2010 403

Figure 18-9: Potential Competitors, Vulnerable Plaque Device Market, Europe,

2010 – 2017. 408

ABBREVIATIONS 409

LIST OF CHARTS

EXECUTIVE SUMMARY 1

Chart 1-1: Interventional Cardiology Device Market, Europe, 2007 – 2017 (euroM) 1

Chart 1-2: Fastest Growing Interventional Cardiology Markets by Country, 2007

– 2017 . 2

Chart 1-3: Angioplasty Procedures, Europe, 2007 – 2017 .. 3

Chart 1-4: Country Statistics, Portugal, 2010 . 5

Chart 1-5: Coronary Stent Market, Europe, 2007 – 2017 (euroM). 6

Chart 1-6: Coronary Atherectomy Device Market, Europe, 2007 – 2017 (euroM).. 9

Chart 1-7: Diagnostic Coronary Catheter and Guidewire Market, Europe,

2007 – 2017 (euroM) 10

Chart 1-8: Coronary VCD Market, Europe, 2010 – 2017 (euroM). 12

Chart 1-9: Optical Coherence Tomography Device Market, Europe, 2010 – 2017

(euroM).. 13

Chart 1-10: Leading Competitors, Interventional Cardiology Markets, Europe,

2010 .. 15

RESEARCH METHODOLOGY.. 16

EUROPEAN INTERVENTIONAL CARDIOLOGY DEVICE MARKETS 28

Chart 3-1: Interventional Cardiology Device Markets, Europe, 2007 – 2017 (euroM) 33

Chart 3-2: Interventional Cardiology Device Markets Segmented by Device

Type, Europe, 2010. 39

Chart 3-3: Interventional Cardiology Device M

To order this report:

: European Markets for Interventional Cardiology Devices 2011 (15 Countries)

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... -- PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for ... Company also filed its Quarterly Report on Form 10-Q for ... and Exchange Commission today. --> ... --> --> Net sales for the three ... to $5.4 million from $2.8 million for the three months ...
(Date:2/11/2016)... 11, 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ... the lives of pets, today announced the submission to ... Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  ... of Zimeta for the control of pyrexia (fever) in ... --> --> The Chemistry, Manufacturing, ...
(Date:2/11/2016)... , Feb. 11, 2016  Governor Andrew M. ... will create 1,400 jobs throughout Western New ... partnership with the SUNY Polytechnic Institute, includes a major ... Building in Buffalo , as well ... manufacturing facility in Dunkirk . The ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 12, 2016 , ... The Journal ... up from 0.416 in 2013. The SJR uses data taken from the Scopus database ... both the number of citations received by the journal over a three year period ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hall Integrative Health and ... for their simultaneous grand openings in March. All seven practices are set to ... wondering, is reversing diabetes possible? According to this 2011 CNN article it is ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for Plans and ... health care system that’s partnering with Intel on value-based health benefits program Connected ...
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
(Date:2/11/2016)... Long Island, NY (PRWEB) , ... February 11, ... ... (INS) has enhanced and updated its hallmark resource, Infusion Therapy Standards of Practice, ... global leader in vein illumination with an estimated 85% share of the market, ...
Breaking Medicine News(10 mins):